The Cigna Group$271.10COR · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B |
| Selling, General & Administrative | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B |
| Operating Expenses | $6.99B | $6.09B | $5.72B | — | — | — | — | — |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | -$5.14B | $1.11B | $1.44B |
| Other Income / (Expense) | -$78.72M | -$14.28M | $49.04M | $27.35M | $41.74M | $1.58M | $12.95M | -$25.47M |
| Income Before Taxes | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | -$5.29B | $967.11M | $1.18B |
| Provision for Income Taxes | $690.52M | $484.70M | $428.26M | $516.52M | $677.25M | -$1.89B | $112.97M | -$438.47M |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | -$3.41B | $855.37M | $1.66B |
| Basic EPS | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | -$16.65 | $4.07 | $7.61 |
| Diluted EPS | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | -$16.65 | $4.04 | $7.53 |
| Basic Shares Outstanding | 193.82M | 198.50M | 202.51M | 208.47M | 205.92M | 204.78M | 210.16M | 217.87M |
| Diluted Shares Outstanding | 195.21M | 200.28M | 204.59M | 211.21M | 208.47M | 204.78M | 211.84M | 220.34M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Sep 2026 | $17.79 | $17.77 | $17.83 | 5 | ↑1 ↓0 |
| Sep 2027 | $19.81 | $19.62 | $20.13 | 6 | ↑1 ↓0 |
| Sep 2028 | $21.66 | $21.40 | $21.97 | 3 | ↑1 ↓0 |
| Sep 2029 | $24.22 | $24.22 | $24.22 | 1 | ↑0 ↓0 |
